Voluntary corporate emissions targets not enough to create real climate action
Imperial and CNRS strengthen UK-France science with new partnerships
New AI startup accelerator led by Imperial opens for applications
11 March 2024
Global human challenge consortium to push for next generation of vaccines
04 February 2024
First UK patients receive experimental mRNA therapy for cancer
21 March 2023
Advanced brain imaging study hints at how DMT alters perception of reality
03 February 2023
Kisspeptin hormone injection could treat low sex drive in women and men
16 August 2022
Imperial addiction researchers showcase work to improve treatments & reduce harm
11 April 2022
Magic mushroom compound increases brain connectivity in people with depression
01 February 2021
COVID Vaccine Trial Participants at Imperial CRF share their Experience
09 December 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2
25 November 2020
Chancellor sees cutting-edge medical research at Imperial
24 April 2020
NIHR Imperial Clinical Research Facility: the London site for the Oxford COVID-1
04 February 2020
Acceleron Announces Sotatercept Achieved Primary and Secondary Endpoints
19 November 2019
Ayahuasca compound changes brainwaves to vivid ‘waking-dream’ state